Human Metapneumovirus Infection

All Human Metapneumovirus Infection Articles

• Review of antibody-based strategies against RSV and SARS-CoV-2 in infants
• Hospitalized children with HMPV infection had 28.0% severe CAP rates and higher risks of wheezing and co-infection
• Survey finds physicians show stronger intergroup bias than public on vaccines
• Narrative review on pediatric RSV co-infections and post-pandemic rebound
• Infection status associated with hypoxemia and death rates varying by virus type in a large US cohort
• Methodological review assesses phenotypes for classifying respiratory viruses in English health data
• Adjuvanted RSV vaccine shows efficacy against RSV disease in older adults with comorbidities
• Measles incidence increased in Galmudug State, Somalia, from 2023 to 2024
• Meta-analysis finds RSV outcomes peak in early infancy in low- and middle-income countries
• ARTIC-based amplicon sequencing assay evaluated for respiratory syncytial virus detection accuracy and lineage identification
• Night-light intensity and temporal factors associated with increased measles incidence in Ethiopia
• Mass vaccination campaign conducted among Afghan evacuees in US after measles cases
• Field report describes measles response effort among Afghan evacuees at New Jersey base
• Field report describes measles outbreak in central Ohio community
• WHO and CDC report updates on global measles cases and vaccination coverage trends
• US adult vaccination coverage for influenza, COVID-19, and RSV reported in observational data
• Report examines vaccination coverage for influenza, RSV, and COVID-19 in US nursing home residents
• Report describes worldwide progress toward regional measles elimination goals
• WHO African Region progress toward measles elimination assessed from 2017 to 2021
• RSV disease severity compared to COVID-19 and influenza in hospitalized older adults
• Human metapneumovirus and respiratory syncytial virus co-circulation described in US
• Report describes progress toward global measles elimination in worldwide population
• Community cohort study examines symptomatic human metapneumovirus infection incidence
• Suspected measles case reported in unvaccinated child in Clark County, Washington
• Measles vaccine coverage increased in Eastern Mediterranean children but remains below elimination target
• Field report describes nirsevimab rollout for RSV prevention in New York City infants
• Measles outbreak reported among unvaccinated children in Illinois apartment complex
• CDC surveillance report details measles cases from 25 U.S. jurisdictions
• Measles outbreak reported among individuals associated with a Chicago migrant shelter
• RSV vaccine safety findings reported one year after recommendation for adults 60 and older
• Measles outbreak reported in New Mexico, details on population and interventions not provided
• Measles outbreak in Colorado linked to exposure from an infectious international traveler
• PRIORIX vaccine recommended for measles, mumps, and rubella protection in the United States
• Symptom clusters from participatory surveillance data align with specific respiratory pathogens in Dutch and Italian cohorts
• ACIP recommends RSV vaccination for adults 60 years and older in the United States
• ACIP Recommends Nirsevimab for Severe RSV Prevention in Infants and Young Children
• RSV Immunization Coverage Among US Infants Receiving Nirsevimab or Maternal Vaccination
• CDC recommends clesrovimab for preventing severe RSV lower respiratory infections in infants
• Palivizumab reduces medically attended RSV infections in preterm infants, shows similar efficacy to nirsevimab
• Case report: Initial positive measles IgM tests in two Samoan children were false positives